|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 7 of 23 found articles
| Title: |
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial |
| Author: |
Paz-Ares, Luis Borghaei, Hossein Liu, Stephen V Peters, Solange Herbst, Roy S Stencel, Katarzyna Majem, Margarita Şendur, Mehmet Ali Nahit Czyżewicz, Grzegorz Caro, Reyes Bernabé Lee, Ki Hyeong Johnson, Melissa L Karadurmuş, Nuri Grohé, Christian Baka, Sofia Csőszi, Tibor Ahn, Jin Seok Califano, Raffaele Yang, Tsung-Ying Kemal, Yasemin Ballinger, Marcus Cuchelkar, Vaikunth Graupner, Vilma Lin, Ya-Chen Chakrabarti, Debasis Bhatt, Kamalnayan Cai, George Iannone, Robert Reck, Martin |
| Appeared in: |
Lancet |
| Paging: | Volume 405 () nr. 10495 pages 2129-2143 |
| Year: |
2025 |
| Contents: | |
| Publisher: |
Copyright © 2025 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 7 of 23 found articles
| << previous | next >> |